720 related articles for article (PubMed ID: 30586741)
1. Glucose-Sensitive Myokine/Cardiokine MG53 Regulates Systemic Insulin Response and Metabolic Homeostasis.
Wu HK; Zhang Y; Cao CM; Hu X; Fang M; Yao Y; Jin L; Chen G; Jiang P; Zhang S; Song R; Peng W; Liu F; Guo J; Tang L; He Y; Shan D; Huang J; Zhou Z; Wang DW; Lv F; Xiao RP
Circulation; 2019 Feb; 139(7):901-914. PubMed ID: 30586741
[TBL] [Abstract][Full Text] [Related]
2. MG53 is not a critical regulator of insulin signaling pathway in skeletal muscle.
Philouze C; Turban S; Cremers B; Caliez A; Lamarche G; Bernard C; Provost N; Delerive P
PLoS One; 2021; 16(2):e0245179. PubMed ID: 33566837
[TBL] [Abstract][Full Text] [Related]
3. Upregulation of MG53 induces diabetic cardiomyopathy through transcriptional activation of peroxisome proliferation-activated receptor α.
Liu F; Song R; Feng Y; Guo J; Chen Y; Zhang Y; Chen T; Wang Y; Huang Y; Li CY; Cao C; Zhang Y; Hu X; Xiao RP
Circulation; 2015 Mar; 131(9):795-804. PubMed ID: 25637627
[TBL] [Abstract][Full Text] [Related]
4. Central role of E3 ubiquitin ligase MG53 in insulin resistance and metabolic disorders.
Song R; Peng W; Zhang Y; Lv F; Wu HK; Guo J; Cao Y; Pi Y; Zhang X; Jin L; Zhang M; Jiang P; Liu F; Meng S; Zhang X; Jiang P; Cao CM; Xiao RP
Nature; 2013 Feb; 494(7437):375-9. PubMed ID: 23354051
[TBL] [Abstract][Full Text] [Related]
5. Cardiac Ischemic Preconditioning Promotes MG53 Secretion Through H
Shan D; Guo S; Wu HK; Lv F; Jin L; Zhang M; Xie P; Wang Y; Song Y; Wu F; Lan F; Hu X; Cao CM; Zhang Y; Xiao RP
Circulation; 2020 Sep; 142(11):1077-1091. PubMed ID: 32677469
[TBL] [Abstract][Full Text] [Related]
6. MG53 and disordered metabolism in striated muscle.
Hu X; Xiao RP
Biochim Biophys Acta Mol Basis Dis; 2018 May; 1864(5 Pt B):1984-1990. PubMed ID: 29017896
[TBL] [Abstract][Full Text] [Related]
7. Negative regulation of AMPK signaling by high glucose via E3 ubiquitin ligase MG53.
Jiang P; Ren L; Zhi L; Yu Z; Lv F; Xu F; Peng W; Bai X; Cheng K; Quan L; Zhang X; Wang X; Zhang Y; Yang D; Hu X; Xiao RP
Mol Cell; 2021 Feb; 81(3):629-637.e5. PubMed ID: 33400924
[TBL] [Abstract][Full Text] [Related]
8. MG53 Does Not Manifest the Development of Diabetes in
Wang Q; Bian Z; Jiang Q; Wang X; Zhou X; Park KH; Hsueh W; Whitson BA; Haggard E; Li H; Chen K; Cai C; Tan T; Zhu H; Ma J
Diabetes; 2020 May; 69(5):1052-1064. PubMed ID: 32139593
[TBL] [Abstract][Full Text] [Related]
9. Infusion of adipose‑derived mesenchymal stem cells inhibits skeletal muscle mitsugumin 53 elevation and thereby alleviates insulin resistance in type 2 diabetic rats.
Deng Z; Xu H; Zhang J; Yang C; Jin L; Liu J; Song H; Chen G; Han W; Si Y
Mol Med Rep; 2018 Jun; 17(6):8466-8474. PubMed ID: 29693163
[TBL] [Abstract][Full Text] [Related]
10. Lack of MG53 in human heart precludes utility as a biomarker of myocardial injury or endogenous cardioprotective factor.
Lemckert FA; Bournazos A; Eckert DM; Kenzler M; Hawkes JM; Butler TL; Ceely B; North KN; Winlaw DS; Egan JR; Cooper ST
Cardiovasc Res; 2016 May; 110(2):178-87. PubMed ID: 26790476
[TBL] [Abstract][Full Text] [Related]
11. Blocking MG53
Lv F; Wang Y; Shan D; Guo S; Chen G; Jin L; Zheng W; Feng H; Zeng X; Zhang S; Zhang Y; Hu X; Xiao RP
Circ Res; 2022 Dec; 131(12):962-976. PubMed ID: 36337049
[TBL] [Abstract][Full Text] [Related]
12. MG53-induced IRS-1 ubiquitination negatively regulates skeletal myogenesis and insulin signalling.
Yi JS; Park JS; Ham YM; Nguyen N; Lee NR; Hong J; Kim BW; Lee H; Lee CS; Jeong BC; Song HK; Cho H; Kim YK; Lee JS; Park KS; Shin H; Choi I; Lee SH; Park WJ; Park SY; Choi CS; Lin P; Karunasiri M; Tan T; Duann P; Zhu H; Ma J; Ko YG
Nat Commun; 2013; 4():2354. PubMed ID: 23965929
[TBL] [Abstract][Full Text] [Related]
13. MG53 is a double-edged sword for human diseases.
Zhang Y; Wu HK; Lv FX; Xiao RP
Sheng Li Xue Bao; 2016 Aug; 68(4):505-16. PubMed ID: 27546510
[TBL] [Abstract][Full Text] [Related]
14. MG53, A Novel Regulator of KChIP2 and I
Liu W; Wang G; Zhang C; Ding W; Cheng W; Luo Y; Wei C; Liu J
Circulation; 2019 Apr; 139(18):2142-2156. PubMed ID: 30760025
[TBL] [Abstract][Full Text] [Related]
15. MG53: Biological Function and Potential as a Therapeutic Target.
Zhang Y; Wu HK; Lv F; Xiao RP
Mol Pharmacol; 2017 Sep; 92(3):211-218. PubMed ID: 28432201
[TBL] [Abstract][Full Text] [Related]
16. MG53 E3 Ligase-Dead Mutant Protects Diabetic Hearts From Acute Ischemic/Reperfusion Injury and Ameliorates Diet-Induced Cardiometabolic Damage.
Feng H; Shen H; Robeson MJ; Wu YH; Wu HK; Chen GJ; Zhang S; Xie P; Jin L; He Y; Wang Y; Lv F; Hu X; Zhang Y; Xiao RP
Diabetes; 2022 Feb; 71(2):298-314. PubMed ID: 34844991
[TBL] [Abstract][Full Text] [Related]
17. An MG53-IRS1-interaction disruptor ameliorates insulin resistance.
Park JS; Lee H; Choi BW; Ro S; Lee D; Na JE; Hong JH; Lee JS; Kim BW; Ko YG
Exp Mol Med; 2018 Jun; 50(6):1-12. PubMed ID: 29884820
[TBL] [Abstract][Full Text] [Related]
18. MG53-IRS-1 (Mitsugumin 53-Insulin Receptor Substrate-1) Interaction Disruptor Sensitizes Insulin Signaling in Skeletal Muscle.
Lee H; Park JJ; Nguyen N; Park JS; Hong J; Kim SH; Song WY; Kim HJ; Choi K; Cho S; Lee JS; Kim BW; Ko YG
J Biol Chem; 2016 Dec; 291(52):26627-26635. PubMed ID: 27810898
[TBL] [Abstract][Full Text] [Related]
19. Response by Wu et al to Letter Regarding Article, "Glucose-Sensitive Myokine/Cardiokine MG53 Regulates Systemic Insulin Response and Metabolic Homeostasis".
Wu HK; Zhang Y; Chen G; Hu X; Lv F; Xiao RP
Circulation; 2019 Aug; 140(6):e188-e189. PubMed ID: 31381417
[No Abstract] [Full Text] [Related]
20. Glucose Sensing by Skeletal Myocytes Couples Nutrient Signaling to Systemic Homeostasis.
Meng ZX; Gong J; Chen Z; Sun J; Xiao Y; Wang L; Li Y; Liu J; Xu XZS; Lin JD
Mol Cell; 2017 May; 66(3):332-344.e4. PubMed ID: 28475869
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
